Table 2.
Tumor characteristics of patients with urothelial bladder cancer (BC).
| BC Cases N = 132 |
|
|---|---|
| Point of inclusion | |
| Pre-TURB | 64 (48.5) |
| Pre-cystectomy | 68 (51.5) |
| Histology | |
| Urothelial cancer | 116 (87.9) |
| Squamous cell features | 12 (9.1) |
| Sarcomatoid features | 3 (2.3) |
| Missing | 1 (0.8) |
| Grade | |
| 1 | 13 (9.8) |
| 2 | 25 (18.9) |
| 3 | 72 (54.5) |
| Low grade | 22 (16.7) |
| High grade | 88 (66.7) |
| Missing | 22 (16.7) |
| cT-stage | |
| Tis–T1 | 49 (37.1) |
| T2–4 | 71 (53.8) |
| Missing | 12 (9.1) |
| pT-stage | |
| T0 | 14 (10.6) |
| Ta | 27 (20.5) |
| Tis | 5 (3.8) |
| T1 | 19 (14.4) |
| T2 | 30 (22.7) |
| T3 | 25 (18.9) |
| T4 | 12 (9.1) |
| cN-stage | |
| N0 | 125 (94.7) |
| N1 | 7 (5.3) |
| pN-stage | |
| N0 | 50 (37.9) |
| N1 | 30 (22.7) |
| Missing * | 52 (39.4) |
| M-stage | |
| M0 | 104 (78.8) |
| M1 | 20 (15.2) |
| Missing | 8 (6.1) |
| Cause of Death | |
| BC | 13 (59.1) |
| Unrelated to BC | 9 (40.9) |
|
Follow-up time (months) Median (IQR) |
7.0 (10.9) |
Tx—no sign of tumor, T0 = No evidence of residual tumor after cystectomy; TUR-B—Transurethral resection of bladder, cT-stage—clinical T-stage, cN-stage- clinical N-stage, pT-stage—pathological T-stage, pN-stage—pathological N-stage, M-stage—Metastatic stage, BC—Urinary bladder cancer, IQR—Interquartile range; * No lymph node dissection performed.